14.05.2013 Views

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

effects or malformations have been reported.<br />

Theophyll<strong>in</strong>e pharmacok<strong>in</strong>etics<br />

are unaffected by pregnancy, and this<br />

drug also appears <strong>in</strong> breast milk.<br />

Betagonists:<br />

These have little systemic absorption<br />

and a more potent bronchodilatory effect<br />

via <strong>in</strong>halation. Data on the use <strong>of</strong> <strong>in</strong>haled<br />

beta-agonists showed no difference <strong>in</strong><br />

per<strong>in</strong>atal mortality, congenital malformations,<br />

birth weight, or Apgar scores.<br />

Corticosteroids:<br />

The use <strong>of</strong> corticosteroids dur<strong>in</strong>g<br />

pregnancy cont<strong>in</strong>ues to be controversial,<br />

although numerous reports confirm their<br />

use without adverse fetal effects. In 3<br />

reports on human pregnancies, no congenital<br />

malformations or adverse fetal<br />

effects were found from <strong>in</strong>haled corticosteroids.<br />

Prednisone has been used extensively<br />

dur<strong>in</strong>g pregnancy for a variety <strong>of</strong><br />

conditions. It is associated with an<br />

<strong>in</strong>creased <strong>in</strong>cidence <strong>of</strong> cleft palates <strong>in</strong><br />

animals but not <strong>in</strong> humans.<br />

Ipratropium and bromide:<br />

Neither <strong>of</strong> these medications has been<br />

associated with adverse fetal outcomes.<br />

Antihistam<strong>in</strong>es and decongestants:<br />

Patients frequently request these<br />

medications for nasal symptoms,<br />

mucosal edema, and hyperemia that<br />

accompany normal pregnancy. The<br />

available data does not <strong>in</strong>dicate safety <strong>of</strong><br />

antihist-am<strong>in</strong>es <strong>in</strong> pregnancy.<br />

Brompheniram<strong>in</strong>e is associated with<br />

congenital malformations.<br />

102<br />

Common antibiotics used for<br />

respiratory <strong>in</strong>fections:<br />

The major antibiotics considered safe<br />

dur<strong>in</strong>g pregnancy are penicill<strong>in</strong>, cephalospor<strong>in</strong>s,<br />

and erythromyc<strong>in</strong>. Although<br />

penicill<strong>in</strong> and ampicill<strong>in</strong> readily cross<br />

the placenta, no adverse effects to the<br />

fetus are reported. Cephalospor<strong>in</strong>s also<br />

traverse the placenta to a moderate<br />

degree, but no adverse fetal effects<br />

occur. Erythromyc<strong>in</strong> crosses the placenta<br />

to a low degree but achieves high levels<br />

<strong>in</strong> breast milk. The estolate formulation<br />

is contra<strong>in</strong>dicated due to potential<br />

hepatic toxicity <strong>in</strong> the mother. Antibiotics<br />

that have relative contra<strong>in</strong>-dications<br />

<strong>in</strong>clude sulfonamides, trime-thoprim,<br />

am<strong>in</strong>oglycosides, nitr<strong>of</strong>uran-to<strong>in</strong>,<br />

antituberculosis drugs, tetracyc-l<strong>in</strong>es,<br />

and qu<strong>in</strong>olones.<br />

Teratogens used <strong>in</strong> pulmonary<br />

disease:<br />

These drugs <strong>in</strong>clude iod<strong>in</strong>e-conta<strong>in</strong><strong>in</strong>g<br />

compounds. Brompheniram<strong>in</strong>e, antihistam<strong>in</strong>e,<br />

coumar<strong>in</strong>, and anticoagulants cause<br />

various teratogenic effects. Cipr<strong>of</strong>loxac<strong>in</strong>,<br />

sulfonamides, tetracycl<strong>in</strong>es, chloramphenicol,<br />

streptomyc<strong>in</strong>, and rifamp<strong>in</strong><br />

have been associated with various<br />

effects. Ioniz<strong>in</strong>g radiation exposure to<br />

the fetus is associated with growth<br />

retardation, CNS effects, microcephaly,<br />

and eye malformations.<br />

Maternal radiation exposure <strong>of</strong> less than<br />

0.05 Gy is associated with no adverse<br />

effects, a dose <strong>of</strong> 0.05-0.1 Gy is<br />

considered the gray zone, and exposure<br />

to more than 0.1 Gy is associated with<br />

significant fetal effects. Fetal ioniz<strong>in</strong>g<br />

radiation might cause <strong>in</strong>creases <strong>in</strong><br />

childhood leukemia. A chest radiograph<br />

results <strong>in</strong> 0.002-Gy exposure; perfusion<br />

lung scan, 0.002 Gy; ventilation lung

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!